FGF21 and obesity due to melanocortin 4 receptor deficiency: Although FGF21 has several beneficial effects for glucose and lipid metabolism1,2, circulating FGF21 levels are paradoxically increased in hepatosteatosis, obesity, and type 2 diabetes1–8.